Form 4/A for ZURA Zura Bio Ltd
Accepted 2024-09-06 00:00:00 ET · period of report 2024-04-22 · accession 0001415889-24-023028 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| A | 2024-09-06 | 2024-04-22 | ZURA | Munshi Amit | Dir | A - Grant | $3.13 | +159.7K | 777.4K | +26% | +$500.0K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A ordinary shares | 2024-04-22 | A | A | 159,744 | $3.13 | 777,384 | D | — | — | (F2) These shares were acquired in a private placement transaction pursuant to the terms of that certain Securities Purchase Agreement, dated as of April 18, 2024, between the Issuer and the Reporting Person at a purchase price of $3.13 per share. |